Navigation Links
Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
Date:7/12/2010

smoking cessation.

About the Staccato-based Product Candidate Development Strategy

In early 2009, Alexza consolidated its operations and reduced spending on its development pipeline, choosing a primary focus on the continued rapid development of AZ-004 (Staccato loxapine).  During 2009, all of the remaining pre-NDA clinical, non-clinical and manufacturing work for AZ-004 was completed, resulting in the NDA filing in December.  In early 2010, Alexza established its first commercial agreement for AZ-004 with Biovail for the U.S. and Canada, received notification of the AZ-004 PDUFA date and continued on the pathway towards AZ-004 commercialization, assuming regulatory approval for marketing.  In the first half of 2010, Alexza conducted a thorough review of its product pipeline, evaluating current and potential new Staccato-based product candidates.  The result of this review yielded three categories of Staccato-based product candidates: (1) those product candidates where Alexza believes it can add value through internal development, (2) those product candidates where Alexza has developed the product idea, but where a development partner is required, and (3) product candidates based on new ideas, primarily focused on new chemical entities, where the Staccato technology can facilitate better or more effective delivery and pharmacology.

"As we have previously stated, the Staccato system technology is a broad technology platform and Alexza has more product candidates than it can currently effectively develop," explained King.  "We embarked on a review of our pipeline to prioritize the product candidates we might develop ourselves and the product candidates we would develop through a partnership or collaboration.  Today we are announcing the first in what
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
2. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
3. Alexza Pharmaceuticals to Present at The Ninth Annual JMP Securities Research Conference
4. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
5. Alexza Pharmaceuticals Files Shelf Registration Statement
6. Alexza to Announce 2010 First Quarter Financial Results on Monday, May 10, 2010
7. Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
8. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
9. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
10. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
11. Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... CITY, Calif., Aug. 3, 2015 AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies ... business update and reported financial results for the three ... Business highlights include: , On July 23, 2015, ... adopted a positive opinion for Zalviso™ for the management ...
(Date:8/3/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest ... June 30, 2015. All comparisons, unless otherwise noted, are to ... Quarter 2015 Highlights include: , Revenue of $808 ... Total prescriptions dispensed of 234,000, an increase of 19% ... EBITDA of $22.7 million, an increase of 287% or $16.8 ...
(Date:8/3/2015)... PARSIPPANY, N.J. , Aug. 3, 2015  LEO ... and Drug Administration (FDA) to include psoriasis as one ... Focused Drug Development Initiative i .  Psoriasis is an ... lives and subsequent comorbidities, affecting 7.5 million people in ... of LEO Pharma,s ongoing commitment to supporting patients living ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5Diplomat Announces 2nd Quarter 2015 Financial Results 6Diplomat Announces 2nd Quarter 2015 Financial Results 7Diplomat Announces 2nd Quarter 2015 Financial Results 8Diplomat Announces 2nd Quarter 2015 Financial Results 9Diplomat Announces 2nd Quarter 2015 Financial Results 10Diplomat Announces 2nd Quarter 2015 Financial Results 11Diplomat Announces 2nd Quarter 2015 Financial Results 12Diplomat Announces 2nd Quarter 2015 Financial Results 13Diplomat Announces 2nd Quarter 2015 Financial Results 14Diplomat Announces 2nd Quarter 2015 Financial Results 15Diplomat Announces 2nd Quarter 2015 Financial Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 17Diplomat Announces 2nd Quarter 2015 Financial Results 18LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 2LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 3
... Calif. , April 26 EMBEDDED ... is providing ultrasound OEMs with a complete 64-channel ... IV FPGAs and Samplify Systems, SAM1600 ADC and ... Doppler (CWD) processing capabilities, the solution can be ...
... , RYE, N.Y. , April 26 Curemark, ... on the treatment of neurological diseases, announced that the company is now ... at the UC Davis MIND Institute (Medical Investigation of Neurodevelopmental Disorders). , ... UC Davis MIND Institute joins ...
Cached Medicine Technology:Samplify Announces Ultrasound Reference Design 2Samplify Announces Ultrasound Reference Design 3Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites 2Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites 3
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... to Los Angeles commercial customers. Finding reliable hardware can be difficult and ... When putting an office together or designing a new facility, it is ...
(Date:8/4/2015)... ... , ... Angelina Jolie is in it at age 39. “It” is menopause, ... Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s leading ... menopause. , Myth #1: Menopause only affects old ladies. – Menopause can affect ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... General of the United States, Richard Carmona, M.D., M.P.H., FACS, to its Board ... medication errors and will save lives," Dr. Carmona said. "I strongly believe in ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... School is ... summer in the sun and preparing for the back-to-school scramble. Dublin, OH family ... is the best time for the annual dental checkup. In fact, the dentist recently ...
(Date:8/4/2015)... Thailand (PRWEB) , ... August 04, 2015 , ... ... United Kingdom and other international locations have shown a rise in binge drinking ... consistent link between binge drinking and depression, are continuing to examine trends and ...
Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3
... MTA: CTIC) today announced that Richard Van der Jagt, M.D. of Ottawa Hospital will be ... Lymphoma Conference on Monday, June 22, 2009. The conference will be held from June 22-26, ... , , ... 2009 Pan Pacific Lymphoma Conference, ...
... , , , President Obama Calls For Health ... 15 The American Medical Association warmly welcomed U.S. ... Like the president, the AMA is committed to health reform this ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) , ...
... June 15 Harry Leider, M.D., MBA, FACPE, Ameritox,s Senior ... President and Chairman of the Board for the American College ... than 10,000 physician leaders. , , Dr. Leider ... a core faculty member within the College for 13 years ...
... Call Scheduled for Tomorrow Morning Tuesday, June 16, 2009 at ... June 15 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... purchase all of the equity of Symphony Allegro. The ... approval, is projected to close in Q3 2009. , ...
... , ATLANTA, June 15 Citing evidence that even a very ... any age, the Council of State and Territorial Epidemiologists (CSTE) is ... levels in adults. In a vote at the CSTE annual conference ... levels of 10 ug/dl or more in adults as "elevated" -- ...
... a study published in The Journal of Infectious ... of Yeshiva University have identified cells in blood that ... deadly fungal meningitis, a major cause of HIV-related death. ... people globallymost of them in sub-Saharan Africa and other ...
Cached Medicine News:Health News:President Obama Receives Warm Welcome from AMA Physicians 2Health News:Ameritox(R) CMO Elected Chairman of the American College of Physician Executives Board 2Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 2Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 3Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 4Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 5Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 6Health News:CSTE Leads Effort to Improve Blood Lead Reporting 2Health News:CSTE Leads Effort to Improve Blood Lead Reporting 3Health News:Predicting fatal fungal infections 2
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
... rHead Radial Implant System provides todays ... to radial head replacement. Modular ... patient anatomy while minimizing ligamentous and ... designed alignment guide assists in both ...
For connection to the bipolar output of electrosurgical generators....
This table has adjustable height, an integral leg, and blade post. Includes a standard 2" (5 cm) pad....
Medicine Products: